PRECISION BIOSCIENCES INC (DTIL) Return on equity 2018–2025
PRECISION BIOSCIENCES INC (DTIL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-49.6%FY2025 · since FY2018: -115.2% → -49.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -49.6% | -62.3 pp |
| FY2024 | 12.7% | +337.8 pp |
| FY2023 | -325.1% | -140.4 pp |
| FY2022 | -184.7% | -151.2 pp |
| FY2021 | -33.6% | +211.8 pp |
| FY2020 | -245.4% | -178.2 pp |
| FY2019 | -67.1% | +48.1 pp |
| FY2018 | -115.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More DTIL financial trends
DTIL RevenueDTIL Net incomeDTIL Net marginDTIL Gross profitDTIL Gross marginDTIL Operating incomeDTIL Operating marginDTIL Operating cash flowDTIL Free cash flowDTIL Capital expendituresDTIL Stock buybacksDTIL Dividends paidDTIL Total assetsDTIL Total liabilitiesDTIL Shareholders’ equityDTIL overview →